PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.07 - 0.07
0.04 - 0.15
840.0K / 2.59M (Avg.)
-2.33 | -0.03
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
22.58%
Revenue growth at 50-75% of 8070.HK's 36.18%. Martin Whitman would worry about competitiveness or product relevance.
-39.54%
Negative gross profit growth while 8070.HK is at 32.42%. Joel Greenblatt would examine cost competitiveness or demand decline.
-103.88%
Negative EBIT growth while 8070.HK is at 185.20%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-119.64%
Negative operating income growth while 8070.HK is at 179.83%. Joel Greenblatt would press for urgent turnaround measures.
-114.05%
Negative net income growth while 8070.HK stands at 210.73%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-113.79%
Negative EPS growth while 8070.HK is at 210.17%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-113.79%
Negative diluted EPS growth while 8070.HK is at 210.17%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
-0.32%
Reduced diluted shares while 8070.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
190.10%
10Y CAGR of 190.10% while 8070.HK is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
161.68%
5Y revenue/share CAGR similar to 8070.HK's 147.27%. Walter Schloss might see both companies benefiting from the same mid-term trends.
73.77%
3Y revenue/share CAGR at 50-75% of 8070.HK's 107.87%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-116.88%
Negative 10Y net income/share CAGR while 8070.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-12.13%
Negative 5Y net income/share CAGR while 8070.HK is 254.26%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
97.30%
Below 50% of 8070.HK's 2329.70%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
138.95%
Equity/share CAGR of 138.95% while 8070.HK is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-15.89%
Negative 5Y equity/share growth while 8070.HK is at 3.44%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
16.48%
3Y equity/share CAGR at 50-75% of 8070.HK's 27.45%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.57%
We cut SG&A while 8070.HK invests at 0.77%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.